UTHR- United Therapeutics Corporation
United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 88 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | Rothblatt Martine A | 66.0K | $35.41M | - |
| VP | Mahon Paul A | 44.5K | $23.88M | - |
| CEO | 40.5K | $21.74M | -28,500 | |
| VP | 33.5K | $17.98M | - | |
| CFO | Edgemond James | 19.9K | $10.67M | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $539.54 | $5,125,646.80 | -14.7% | +1.5% | - | |
| Mar 10, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $539.71 | $5,127,273.03 | -10.7% | +2.6% | - | |
| Mar 5, 2026 | Mahon Paul A47 | EVP &General Counsel | Sale+OE | 8,300 | $483.16 | $4,010,187.14 | -2.2% | +12.9% | - | |
| Mar 4, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 19,000 | $317.97 | $6,041,413.58 | -30.9% | +11.1% | - | |
| Mar 4, 2026 | Kurzweil Ray | Director | Sale+OE | 4,910 | $489.02 | $2,401,088.20 | -27.9% | +11.1% | - | |
| Mar 4, 2026 | Thompson Tommy G51 | Director | Sale+OE | 2,000 | $489.42 | $978,839.40 | -19.1% | +11.1% | - | |
| Mar 4, 2026 | Causey Christopher59 | Director | Sale+OE | 20 | $490.17 | $9,803.37 | -0.5% | +11.1% | - | |
| Mar 3, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $499.42 | $4,744,466.67 | -11.5% | +11.7% | - | |
| Mar 2, 2026 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 9,500 | $515.37 | $4,896,019.01 | -11.5% | +8.4% | - | |
| Feb 27, 2026 | Olian Judy D.60 | Director | Sell | 200 | $509.55 | $101,910.00 | -4.0% | +11.5% | - |